28/06/2025 00:12
|
Business & Finance
TOKYO--BUSINESS WIRE--
PRD Therapeutics, Inc., a clinical stage company focused on the development of novel lipid metabolism regulators targeting homozygous familial hypercholesterolemia (HoFH)...